What causes fibro‑osseous lesions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Etiology of Fibro-Osseous Lesions

Fibro-osseous lesions arise from diverse pathogenic mechanisms including developmental abnormalities, reactive/dysplastic processes, and true neoplasms—they are not a single disease entity but rather a heterogeneous group of disorders unified only by their shared microscopic appearance of fibrous stroma containing bone or cementum-like tissue. 1, 2

Pathogenic Categories

The causes of fibro-osseous lesions fall into four distinct mechanistic groups:

Developmental/Dysplastic Processes

  • Fibrous dysplasia represents a developmental disorder caused by post-zygotic somatic mutations in the GNAS gene, leading to abnormal bone remodeling where normal bone is replaced by fibrous tissue and immature woven bone 2
  • Osseous dysplasias constitute a single disease process (despite previous classification controversies) arising from reactive changes in periodontal ligament tissue, typically triggered by local factors 1, 2

Neoplastic Origins

  • Ossifying fibroma is a true benign neoplasm of bone-forming mesenchymal tissue, representing clonal proliferation rather than reactive change 1, 3
  • The "juvenile active" or "psammomatoid" variants remain controversial regarding their exact neoplastic nature, but demonstrate more aggressive biological behavior 1

Reactive/Inflammatory Mechanisms

  • Some fibro-osseous lesions develop as reactive responses to chronic inflammation, trauma, or other local irritants in the jaw bones 3, 2
  • These reactive processes involve abnormal bone remodeling in response to injury or persistent stimulation 2

Genetic Predisposition

  • Certain syndromes with germline mutations predispose to fibro-osseous changes, though these are rare 4
  • Most fibro-osseous lesions are sporadic without identifiable hereditary factors 2

Key Mechanistic Features

The unifying pathologic mechanism across all fibro-osseous lesions involves replacement of normal bone architecture with cellular fibrous connective tissue matrix containing islands or trabeculae of newly formed bone or cementum-like material. 5, 1

  • The specific trigger varies by lesion type: genetic mutations (fibrous dysplasia), neoplastic transformation (ossifying fibroma), or reactive stimuli (osseous dysplasias) 2
  • Despite similar microscopic appearance, these lesions demonstrate vastly different biological behaviors ranging from self-limited to locally aggressive 5, 6

Clinical Implications

Accurate determination of the specific cause requires correlation of clinical presentation, radiographic features, and histopathology—the term "fibro-osseous lesion" should only be used as a working diagnosis, not a final classification. 5, 3

  • Age, location, and radiographic pattern help distinguish developmental from neoplastic causes 3, 6
  • Treatment varies dramatically based on underlying etiology: observation for osseous dysplasias versus surgical excision for ossifying fibromas 3, 6
  • The designation "atypical fibro-osseous lesion" suggests likelihood of aggressive behavior and warrants definitive classification before treatment 5

References

Research

Benign fibro-osseous lesions: a review of current concepts.

Advances in anatomic pathology, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

"Atypical" fibro-osseous lesions: diagnostic challenges and treatment concepts.

International journal of oral and maxillofacial surgery, 1995

Research

Benign fibro-osseous lesions of the jaws in children. A 12-year retrospective study.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.